{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:56:13Z","timestamp":1781632573874,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare survival differences between hemodialysis (HD) and peritoneal dialysis (PD) in elderly patients (\u2265\u200960 years old) with end-stage renal disease (ESRD), and to analyze the impact of key comorbidities (heart failure, cerebrovascular disease, diabetes) on prognosis and causes of death, to inform dialysis modality selection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective cohort study enrolled 377 elderly ESRD patients (216 HD, 161 PD) who initiated dialysis between 2012 and 2017, with follow-up until 2024. Survival rates were compared using the Kaplan-Meier method. The Cox proportional hazards model was used to analyze risk factors for all-cause mortality, and the competing risks model was employed to assess risks for specific causes of death. Subgroup analyses were performed for patients with heart failure, cerebrovascular disease, and diabetes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the overall population, the HD group had a significantly lower risk of all-cause mortality than the PD group (adjusted HR\u2009=\u20090.599, 95% CI: 0.45\u20130.79). Subgroup analyses revealed that the survival advantage of HD was particularly pronounced in patients with concomitant heart failure (adjusted HR\u2009=\u20090.422, 95% CI: 0.25\u20130.70) or diabetes (adjusted HR\u2009=\u20090.687, 95% CI: 0.48\u20130.98). Notably, HD was identified as an independent risk factor for hemorrhagic death (sHR\u2009=\u20098.773, 95% CI: 1.03\u201374.42), with the PD group demonstrating a markedly lower cumulative incidence of such events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For elderly ESRD patients, dialysis modality selection should be individualized based on comorbidities. HD may be associated with a survival benefit and might be prioritized for patients with concomitant heart failure or diabetes. PD may be considered a safer option, particularly for patients with cerebrovascular disease who are at high risk of bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-04783-7","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:06:50Z","timestamp":1769760410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hemodialysis versus peritoneal dialysis in elderly ESRD patients: a retrospective cohort study on survival and the role of comorbidities"],"prefix":"10.1186","volume":"27","author":[{"given":"Ruizhi","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hucai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"03","key":"4783_CR1","first-page":"1","volume":"36","author":"Z Chen","year":"2025","unstructured":"Chen Z, Yu C. The current status and trends of china\u2019s elderly population and disease burden from a global perspective. J Public Health Prev Med. 2025;36(03):1\u20136.","journal-title":"J Public Health Prev Med"},{"issue":"18","key":"4783_CR2","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4103\/0366-6999.213961","volume":"130","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zeng XX, Fu P. Community Hemodialysis in china: opportunities and challenges. Chin Med J (Engl). 2017;130(18):2143\u20136.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"4783_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/ndt\/gfv411","volume":"32","author":"L Segall","year":"2017","unstructured":"Segall L, Nistor I, Van Biesen W, Brown EA, Heaf JG, Lindley E, Farrington K, Covic A. Dialysis modality choice in elderly patients with end-stage renal disease: a narrative review of the available evidence. Nephrol Dial Transpl. 2017;32(1):41\u20139.","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"4783_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1159\/000536648","volume":"70","author":"L Cheng","year":"2024","unstructured":"Cheng L, Hu N, Song D, Chen Y. Mortality of peritoneal Dialysis versus Hemodialysis in older adults: an updated systematic review and meta-analysis. Gerontology. 2024;70(5):461\u201378.","journal-title":"Gerontology"},{"key":"4783_CR5","doi-asserted-by":"crossref","unstructured":"Ahmed FA, Catic AG. Decision-making in geriatric patients with end-stage renal disease: thinking beyond nephrology. J Clin Med 2018, 8(1).","DOI":"10.3390\/jcm8010005"},{"issue":"6","key":"4783_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.31083\/j.rcm2506232","volume":"25","author":"L Guo","year":"2024","unstructured":"Guo L, Ji Y, Sun T, Liu Y, Jiang C, Wang G, Xing H, Yang B, Xu A, Xian X, et al. Management of chronic heart failure in Dialysis patients: A challenging but rewarding path. Rev Cardiovasc Med. 2024;25(6):232.","journal-title":"Rev Cardiovasc Med"},{"issue":"5","key":"4783_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/sdi.12903","volume":"33","author":"TH Chen","year":"2020","unstructured":"Chen TH, Wen YH, Chen CF, Tan AC, Chen YT, Chen FY, Lin CC. The advantages of peritoneal Dialysis over Hemodialysis during the COVID-19 pandemic. Semin Dial. 2020;33(5):369\u201371.","journal-title":"Semin Dial"},{"key":"4783_CR8","doi-asserted-by":"publisher","first-page":"898650","DOI":"10.3389\/fmed.2022.898650","volume":"9","author":"Z He","year":"2022","unstructured":"He Z, Liang H, Huang J, Zhang D, Ma H, Lin J, Cai Y, Liu T, Li H, Qiu W, et al. Impact of Dialysis modality choice on the survival of end-stage renal disease patients with congestive heart failure in Southern china: A retrospective cohort study. Front Med (Lausanne). 2022;9:898650.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"4783_CR9","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.12669\/pjms.39.6.8056","volume":"39","author":"Y Zhao","year":"2023","unstructured":"Zhao Y. Comparison of the effect of Hemodialysis and peritoneal Dialysis in the treatment of end-stage renal disease. Pak J Med Sci. 2023;39(6):1562\u20137.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"4783_CR10","doi-asserted-by":"publisher","first-page":"2321320","DOI":"10.1080\/0886022X.2024.2321320","volume":"46","author":"P Zhang","year":"2024","unstructured":"Zhang P, Xun L, Bao N, Tong D, Duan B, Peng D. Long-term mortality in patients with end-stage renal disease undergoing Hemodialysis and peritoneal dialysis: a propensity score matching retrospective study. Ren Fail. 2024;46(1):2321320.","journal-title":"Ren Fail"},{"issue":"10","key":"4783_CR11","doi-asserted-by":"publisher","first-page":"e0140195","DOI":"10.1371\/journal.pone.0140195","volume":"10","author":"F Yang","year":"2015","unstructured":"Yang F, Khin LW, Lau T, Chua HR, Vathsala A, Lee E, Luo N. Hemodialysis versus peritoneal dialysis: A comparison of survival outcomes in south-east Asian patients with end-stage renal disease. PLoS ONE. 2015;10(10):e0140195.","journal-title":"PLoS ONE"},{"issue":"2","key":"4783_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1681\/ASN.V92267","volume":"9","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Harnett JD, Kent GM, O\u2019Dea R, Murray DC, Barre PE. Mode of Dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9(2):267\u201376.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4783_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1681\/ASN.2007111188","volume":"20","author":"SP McDonald","year":"2009","unstructured":"McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between Dialysis modality and mortality. J Am Soc Nephrol. 2009;20(1):155\u201363.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4783_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2215\/CJN.04810512","volume":"8","author":"LR Lukowsky","year":"2013","unstructured":"Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K. Comparing mortality of peritoneal and Hemodialysis patients in the first 2 years of Dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol. 2013;8(4):619\u201328.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"4783_CR15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ki.2014.224","volume":"86","author":"VA Kumar","year":"2014","unstructured":"Kumar VA, Sidell MA, Jones JP, Vonesh EF. Survival of propensity matched incident peritoneal and Hemodialysis patients in a united States health care system. Kidney Int. 2014;86(5):1016\u201322.","journal-title":"Kidney Int"},{"issue":"3","key":"4783_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000504040","volume":"49","author":"M Banshodani","year":"2020","unstructured":"Banshodani M, Kawanishi H, Moriishi M, Shintaku S, Tsuchiya S. Association between Dialysis modality and cardiovascular diseases: A comparison between peritoneal Dialysis and Hemodialysis. Blood Purif. 2020;49(3):302\u20139.","journal-title":"Blood Purif"},{"issue":"3","key":"4783_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1681\/ASN.2009060635","volume":"21","author":"ED Weinhandl","year":"2010","unstructured":"Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident Hemodialysis and peritoneal Dialysis patients. J Am Soc Nephrol. 2010;21(3):499\u2013506.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4783_CR18","doi-asserted-by":"publisher","first-page":"16199","DOI":"10.1038\/s41598-023-43476-1","volume":"13","author":"YK Peng","year":"2023","unstructured":"Peng YK, Tai TS, Wu CY, Tsai CY, Lee CC, Chen JJ, Hsiao CC, Chen YC, Yang HY, Yen CL. Clinical outcomes between elderly ESKD patients under peritoneal Dialysis and hemodialysis: a National cohort study. Sci Rep. 2023;13(1):16199.","journal-title":"Sci Rep"},{"issue":"9","key":"4783_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ki.2011.233","volume":"80","author":"F Sens","year":"2011","unstructured":"Sens F, Schott-Pethelaz AM, Labeeuw M, Colin C, Villar E. Survival advantage of Hemodialysis relative to peritoneal Dialysis in patients with end-stage renal disease and congestive heart failure. Kidney Int. 2011;80(9):970\u20137.","journal-title":"Kidney Int"},{"issue":"3","key":"4783_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.47391\/JPMA.10296","volume":"74","author":"U Khan","year":"2024","unstructured":"Khan U, Siddiqui MA. Comparative analysis of peritoneal Dialysis and Hemodialysis for the management of kidney failure: A concise review. J Pak Med Assoc. 2024;74(3):617.","journal-title":"J Pak Med Assoc"},{"issue":"6","key":"4783_CR21","doi-asserted-by":"publisher","first-page":"e13758","DOI":"10.1111\/eci.13758","volume":"52","author":"A van Eck","year":"2022","unstructured":"van Eck A, Bonenkamp AA, van Wallene VA, Hoekstra T, Lissenberg-Witte BI, Dekker FW, van Ittersum FJ, Verhaar MC, van Jaarsveld BC, Abrahams AC. Differences in hospitalisation between peritoneal Dialysis and haemodialysis patients. Eur J Clin Invest. 2022;52(6):e13758.","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"4783_CR22","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1177\/19322968231174040","volume":"18","author":"JC Lu","year":"2024","unstructured":"Lu JC, Lee P, Ierino F, MacIsaac RJ, Ekinci E, O\u2019Neal D. Challenges of glycemic control in people with diabetes and advanced kidney disease and the potential of automated insulin delivery. J Diabetes Sci Technol. 2024;18(6):1500\u20138.","journal-title":"J Diabetes Sci Technol"},{"key":"4783_CR23","doi-asserted-by":"crossref","unstructured":"Bronas UG, Puzantian H, Hannan M. Cognitive impairment in chronic kidney disease: vascular milieu and the potential therapeutic role of exercise. Biomed Res Int 2017, 2017:2726369.","DOI":"10.1155\/2017\/2726369"},{"issue":"1","key":"4783_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/jnnp-2019-320526","volume":"91","author":"D Kelly","year":"2020","unstructured":"Kelly D, Rothwell PM. Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry. 2020;91(1):88\u201397.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"4783_CR25","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1093\/ndt\/15.11.1808","volume":"15","author":"K Iseki","year":"2000","unstructured":"Iseki K, Fukiyama K. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis study (OKIDS) group. Nephrol Dial Transpl. 2000;15(11):1808\u201313.","journal-title":"Nephrol Dial Transpl"},{"issue":"3","key":"4783_CR26","first-page":"347","volume":"34","author":"L Belmar","year":"2014","unstructured":"Belmar L, de Francisco AL, Bueno L, Pi\u00f1era C, Monf\u00e1 E, Kislikova M, Seras M, Rodrigo E, Arias M. Strokes in patients on haemodialysis: incidence, onset time and associated factors. Nefrologia. 2014;34(3):347\u201352.","journal-title":"Nefrologia"},{"issue":"5","key":"4783_CR27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2176\/nmc.44.225","volume":"44","author":"M Murakami","year":"2004","unstructured":"Murakami M, Hamasaki T, Kimura S, Maruyama D, Kakita K. Clinical features and management of intracranial hemorrhage in patients undergoing maintenance Dialysis therapy. Neurol Med Chir (Tokyo). 2004;44(5):225\u201332. discussion 233.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"4783_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fcvm.2020.00096","volume":"7","author":"M Miglinas","year":"2020","unstructured":"Miglinas M, Cesniene U, Janusaite MM, Vinikovas A. Cerebrovascular disease and cognition in chronic kidney disease patients. Front Cardiovasc Med. 2020;7:96.","journal-title":"Front Cardiovasc Med"},{"key":"4783_CR29","doi-asserted-by":"publisher","first-page":"963689724123657","DOI":"10.1177\/09636897241236576","volume":"33","author":"M Cheng","year":"2024","unstructured":"Cheng M, Ding Y, Kim E, Geng X. Exploring the therapeutic potential of peritoneal Dialysis (pd) in the treatment of neurological disorders. Cell Transpl. 2024;33:9636897241236576.","journal-title":"Cell Transpl"},{"key":"4783_CR30","doi-asserted-by":"crossref","unstructured":"Barbu E, Mihaila AC, Gan AM, Ciortan L, Macarie RD, Tucureanu MM, Filippi A, Stoenescu AI, Petrea SV, Simionescu M et al. The elevated inflammatory status of neutrophils is related to in-hospital complications in patients with acute coronary syndrome and has important prognosis value for diabetic patients. Int J Mol Sci 2024, 25(10).","DOI":"10.3390\/ijms25105107"},{"issue":"1","key":"4783_CR31","doi-asserted-by":"publisher","first-page":"20230877","DOI":"10.1515\/med-2023-0877","volume":"18","author":"L Pang","year":"2023","unstructured":"Pang L, Ding Z, Chai H, Shuang W. The causal relationship between immune cells and different kidney diseases: A Mendelian randomization study. Open Med (Wars). 2023;18(1):20230877.","journal-title":"Open Med (Wars)"},{"issue":"2","key":"4783_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera A, Soehnlein O, Kenne E. Neutrophils in chronic inflammatory diseases. Cell Mol Immunol. 2022;19(2):177\u201391.","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"4783_CR33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11255-021-03026-y","volume":"54","author":"H Liu","year":"2022","unstructured":"Liu H, He Z, Hu X, Li S, Wang L, Zhao D, Lin Q, Liu X, Lu F, Zhang D. Propensity-matched comparison of mortality between peritoneal Dialysis and Hemodialysis in patients with type 2 diabetes. Int Urol Nephrol. 2022;54(6):1373\u201381.","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"4783_CR34","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/039139889802100808","volume":"21","author":"RT Krediet","year":"1998","unstructured":"Krediet RT. Long-term peritoneal dialysis-impact of peritoneal membrane changes and newer solutions. Int J Artif Organs. 1998;21(8):437\u20139.","journal-title":"Int J Artif Organs"},{"issue":"7","key":"4783_CR35","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.12669\/pjms.36.7.2901","volume":"36","author":"XD Xu","year":"2020","unstructured":"Xu XD, Han X, Yang Y, Li X. Comparative study on the efficacy of peritoneal Dialysis and Hemodialysis in patients with end-stage diabetic nephropathy. Pak J Med Sci. 2020;36(7):1484\u20139.","journal-title":"Pak J Med Sci"},{"issue":"7","key":"4783_CR36","first-page":"e64771","volume":"16","author":"Y Shen","year":"2024","unstructured":"Shen Y. Pathogenesis and mechanism of uremic vascular calcification. Cureus. 2024;16(7):e64771.","journal-title":"Cureus"},{"issue":"2","key":"4783_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1590\/S0101-28002011000200009","volume":"33","author":"TP de Moraes","year":"2011","unstructured":"de Moraes TP, Fortes PC, Ribeiro SC, Riella MC, Pecoits-Filho R. Comparative analysis of lipid and glucose metabolism biomarkers in non-diabetic Hemodialysis and peritoneal Dialysis patients. J Bras Nefrol. 2011;33(2):173\u20139.","journal-title":"J Bras Nefrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04783-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04783-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04783-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:23:20Z","timestamp":1781630600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04783-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4783"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04783-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (Approval Number: ZE2020-054-01), which granted a full waiver of the requirement for informed consent. The waiver was granted as the research involved no more than minimal risk and the use of protected health information was determined to have no adverse impact on the rights and welfare of the participants. The study was conducted in accordance with the ethical standards of the institutional and national research committees and with the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. All data in this retrospective study were thoroughly anonymized and de-identified prior to analysis. The requirement for informed consent for publication was waived by the Ethics Committee of Guangdong Provincial Hospital of Chinese Medicine (Approval Number: ZE2020-054-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}